Combined Photothermal and Ionizing Radiation Sensitization of Triple-Negative Breast Cancer Using Triangular Silver Nanoparticles

References

• Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 2007;8(3):235–244. doi:10.1016/S1470-2045(07)70074-8
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429–4434. doi:10.1158/1078-0432.CCR-06-3045
   PubMed Web of Science ®Google Scholar
• Panoff JE, Hurley J, Takita C, et al. Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Tr. 2011;128(3):899–906. doi:10.1007/s10549-011-1495-1
   PubMedGoogle Scholar
• Gong Y, Liu Y-R, Ji P, Hu X, Shao Z-M. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Scientific Rep. 2017;7(1):45411. doi:10.1038/srep45411
   PubMedGoogle Scholar
• Holleczek B, Stegmaier C, Radosa JC, Solomayer E-F, Brenner H. Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis – results from a registry-based study from Germany. Bmc Cancer. 2019;19(1):520. doi:10.1186/s12885-019-5710-5
   PubMedGoogle Scholar
• Rapiti E, Pinaud K, Chappuis PO, et al. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study. Cancer Med. 2017;6(3):526–536.
   PubMed Web of Science ®Google Scholar
• Steward LT, Gao F, Taylor MA, Margenthaler JA. Impact of radiation therapy on survival in patients with triple-negative breast cancer. Oncol Lett. 2014;7(2):548–552.
   PubMed Web of Science ®Google Scholar
• Abdulkarim BS, Cuartero J, Hanson J, Deschenes J, Lesniak D, Sabri S. Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy. J Clin Oncol. 2011;29(21):2852–2858.
   PubMedGoogle Scholar
• Haffty BG, Yang QF, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24(36):5652–5657.
   PubMed Web of Science ®Google Scholar
• Wang JH, Shi M, Ling R, et al. Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial. Radiother Oncol. 2011;100(2):200–204. doi:10.1016/j.radonc.2011.07.007
   PubMed Web of Science ®Google Scholar
• Dragun AE, Pan JM, Rai SN, Kruse B, Jain D. Locoregional Recurrence in Patients With Triple-Negative Breast Cancer Preliminary Results of a Single Institution Study. Am J Clin Oncol. 2011;34(3):231–237. doi:10.1097/COC.0b013e3181dea993
   PubMed Web of Science ®Google Scholar
• Rice SR, Feigenberg SJ, Hamza M, et al. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis. Breast Cancer Res Tr. 2019;175(2):473–478. doi:10.1007/s10549-019-05150-x
   PubMedGoogle Scholar
• Rippy EE, Ainsworth R, Sathananthan D, Kollias J, Bochner M, Whitfield R. Influences on decision for mastectomy in patients eligible for breast conserving surgery. Breast. 2014;23(3):273–278. doi:10.1016/j.breast.2013.12.009
   PubMedGoogle Scholar
• Lam J, Cook T, Foster S, Poon R, Milross C, Sundaresan P. Examining Determinants of Radiotherapy Access: do Cost and Radiotherapy Inconvenience Affect Uptake of Breast-conserving Treatment for Early Breast Cancer? Clin Oncol. 2015;27(8):465–471. doi:10.1016/j.clon.2015.04.034
   Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Eng J Med. 2013;368(11):987–998. doi:10.1056/NEJMoa1209825
   PubMed Web of Science ®Google Scholar
• Back M. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol. 2004;16(1):12–16. doi:10.1016/j.clon.2003.08.005
   Web of Science ®Google Scholar
• White J, Joiner MC. Toxicity from radiation in breast cancer. Cancer Treat Res. 2006;128:65–109.
   PubMedGoogle Scholar
• Brownlee Z, Garg R, Listo M, Zavitsanos P, Wazer DE, Huber KE. Late complications of radiation therapy for breast cancer: evolution in techniques and risk over time. Gland Surgery. 2018;7(4):371–378. doi:10.21037/gs.2018.01.05
   PubMedGoogle Scholar
• Poortmans PM, Collette L, Horiot J-C, et al. Impact of the boost dose of 10Gy versus 26Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial. Radiother Oncol. 2009;90(1):80–85. doi:10.1016/j.radonc.2008.07.011
   PubMed Web of Science ®Google Scholar
• Vicini FA, Cecchini RS, White JR, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, Phase 3, equivalence trial. Lancet. 2019;394(10215):2155–2164. doi:10.1016/S0140-6736(19)32514-0
   PubMedGoogle Scholar
• Liu P, Jin H, Guo Z, et al. Silver nanoparticles outperform gold nanoparticles in radiosensitizing U251 cells in vitro and in an intracranial mouse model of glioma. Int J Nanomed. 2016;11:5003–5014. doi:10.2147/IJN.S115473
   PubMed Web of Science ®Google Scholar
• Habiba K, Aziz K, Sanders K, et al. Enhancing Colorectal Cancer Radiation Therapy Efficacy using Silver Nanoprisms Decorated with Graphene as Radiosensitizers. Scientific Rep. 2019;9(1):17120. doi:10.1038/s41598-019-53706-0
   PubMedGoogle Scholar
• Swanner J, Mims J, Carroll DL, et al. Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells.. Int J Nanomedicine. 2015;10:3937–3953. doi:10.2147/IJN.S80349
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Zhong Z, Slatkin DN, Kalef-Ezra JA, Smilowitz HM. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol. 2010;55(11):3045–3059. doi:10.1088/0031-9155/55/11/004
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Lin L, Slatkin DN, Dilmanian FA, Vadas TM, Smilowitz HM. Gold nanoparticle hyperthermia reduces radiotherapy dose. Nanomedicine. 2014;10(8):1609–1617. doi:10.1016/j.nano.2014.05.006
   PubMed Web of Science ®Google Scholar
• Atkinson RL, Zhang M, Diagaradjane P, et al. Thermal Enhancement with Optically Activated Gold Nanoshells Sensitizes Breast Cancer Stem Cells to Radiation Therapy. Sci Transl Med. 2010;2(55):55ra79. doi:10.1126/scitranslmed.3001447
   PubMed Web of Science ®Google Scholar
• Wolfe T, Chatterjee D, Lee J, et al. Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo. Nanomedicine. 2015;11(5):1277–1283. doi:10.1016/j.nano.2014.12.016
   PubMed Web of Science ®Google Scholar
• Verry C, Sancey L, Dufort S, et al. Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a Phase I study protocol. BMJ Open. 2019;9(2):e023591. doi:10.1136/bmjopen-2018-023591
   PubMed Web of Science ®Google Scholar
• Bonvalot S, Rutkowski PL, Thariat J, et al. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, Phase 2–3, randomised, controlled trial. Lancet Oncol. 2019;20(8):1148–1159. doi:10.1016/S1470-2045(19)30326-2
   PubMed Web of Science ®Google Scholar
• Pottier A, Borghi E, Levy L. The future of nanosized radiation enhancers. Br J Radiol. 2015;88(1054):20150171. doi:10.1259/bjr.20150171
   PubMedGoogle Scholar
• Howard D, Sebastian S, Le QV-C, Thierry B, Kempson I. Chemical Mechanisms of Nanoparticle Radiosensitization and Radioprotection: A Review of Structure-Function Relationships Influencing Reactive Oxygen Species. Int J Mol Sci. 2020;21(2):579. doi:10.3390/ijms21020579
   PubMedGoogle Scholar
• Swanner J, Fahrenholtz CD, Tenvooren I, et al. Silver nanoparticles selectively treat triple-negative breast cancer cells without affecting non-malignant breast epithelial cells in vitro and in vivo. FASEB Bioadvances. 2019;1(10):639–660. doi:10.1096/fba.2019-00021
   PubMedGoogle Scholar
• Simard J-C, Durocher I, Girard D. Silver nanoparticles induce irremediable endoplasmic reticulum stress leading to unfolded protein response dependent apoptosis in breast cancer cells. Apoptosis. 2016;21(11):1279–1290. doi:10.1007/s10495-016-1285-7
   PubMed Web of Science ®Google Scholar
• Cherukuri P, Glazer ES, Curleya SA. Targeted hyperthermia using metal nanoparticles. Adv Drug Delivery Reviews. 2010;62(3):339–345. doi:10.1016/j.addr.2009.11.006
   PubMed Web of Science ®Google Scholar
• Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D: Appl Phys. 2005;38(15):2543. doi:10.1088/0022-3727/38/15/004
   Web of Science ®Google Scholar
• Nioka S, Chance B. NIR spectroscopic detection of breast cancer. Technol Cancer Res Treat. 2005;4(5):497–512. doi:10.1177/153303460500400504
   PubMedGoogle Scholar
• Xie B, Singh R, Torti FM, Keblinski P, Torti S. Heat localization for targeted tumor treatment with nanoscale near-infrared radiation absorbers. Phys Med Biol. 2012;57(18):5765–5775. doi:10.1088/0031-9155/57/18/5765
   PubMedGoogle Scholar
• Thompson EA, Graham E, MacNeill CM, et al. Differential response of MCF7, MDA-MB-231, and MCF 10A cells to hyperthermia, silver nanoparticles and silver nanoparticle-induced photothermal therapy. Int J Hyperthermia. 2014;30(5):312–323. doi:10.3109/02656736.2014.936051
   PubMed Web of Science ®Google Scholar
• Vernon I, Vernon C, Hand J, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. Int J Radiat Oncol. 1996;35(4):731–744. doi:10.1016/0360-3016(96)00154-X
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497. doi:10.1016/S1470-2045(02)00818-5
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet. 2000;355(9210):1119–1125. doi:10.1016/S0140-6736(00)02059-6
   PubMed Web of Science ®Google Scholar
• Schilling D, Kuhnel A, Konrad S, et al. Sensitizing tumor cells to radiation by targeting the heat shock response. Cancer Lett. 2015;360(2):294–301. doi:10.1016/j.canlet.2015.02.033
   PubMedGoogle Scholar
• Milanovic D, Firat E, Grosu AL, Niedermann G. Increased radiosensitivity and radiothermosensitivity of human pancreatic MIAPaCa-2 and U251 glioblastoma cell lines treated with the novel Hsp90 inhibitorNVP-HSP990. Radiation Oncol. 2013;8(1):42. doi:10.1186/1748-717X-8-42
   PubMedGoogle Scholar
• Myerson RJ, et al. Simultaneous superficial hyperthermia and external radiotherapy: report of thermal dosimetry and tolerance to treatment. Int J Hyperthermia. 1999;15(4):251–266. doi:10.1080/026567399285639
   PubMed Web of Science ®Google Scholar
• Datta NR, Ordóñez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–753. doi:10.1016/j.ctrv.2015.05.009
   PubMed Web of Science ®Google Scholar
• Espinosa A, Curcio A, Cabana S, et al. Intracellular Biodegradation of Ag Nanoparticles, Storage in Ferritin, and Protection by a Au Shell for Enhanced Photothermal Therapy. ACS Nano. 2018;12(7):6523–6535. doi:10.1021/acsnano.8b00482
   PubMedGoogle Scholar
• Holmila RJ, Vance SA, King SB, Tsang AW, Singh R, Furdui CM. Silver Nanoparticles Induce Mitochondrial Protein Oxidation in Lung Cells Impacting Cell Cycle and Proliferation. Antioxidants. 2019;8(11):552. doi:10.3390/antiox8110552
   Web of Science ®Google Scholar
• AshaRani PV, Mun GLK, Hande MP, Valiyaveettil VS. Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells. ACS Nano. 2009;3(2):279–290. doi:10.1021/nn800596w
   PubMed Web of Science ®Google Scholar
• Fahrenholtz CD, Swanner J, Ramirez-Perez M, Singh RN. Heterogeneous Responses of Ovarian Cancer Cells to Silver Nanoparticles as a Single Agent and in Combination with Cisplatin. J Nanomater. 2017;2017:5107485. doi:10.1155/2017/5107485
   PubMedGoogle Scholar
• Huo L, Chen R, Zhao L, et al. Silver nanoparticles activate endoplasmic reticulum stress signaling pathway in cell and mouse models: the role in toxicity evaluation. Biomaterials. 2015;61:307–315. doi:10.1016/j.biomaterials.2015.05.029
   PubMed Web of Science ®Google Scholar
• Gopisetty MK, Kovacs D, Igaz N, et al. Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells. J Nanobiotechnology. 2019;17(1):9. doi:10.1186/s12951-019-0448-4
   PubMed Web of Science ®Google Scholar
• Laszlo A, Fleischer FI. Heat-Induced Perturbations of DNA Damage Signaling Pathways are Modulated by Molecular Chaperones. Cancer Res. 2009;69(5):2042–2049. doi:10.1158/0008-5472.CAN-08-1639
   PubMed Web of Science ®Google Scholar
• Oei AL, Vriend LE, Crezee J, Franken NA, Krawczyk PM. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 2015;10:165.
   PubMed Web of Science ®Google Scholar
• Keblinski P, Cahill DG, Bodapati A, Sullivan CR, Taton TA. Limits of localized heating by electromagnetically excited nanoparticles. J Appl Phys. 2006;100(5):054305.
   Web of Science ®Google Scholar